Thirty years of attempts to reduce coronary heart disease: new proposals.
Explore the source record for details and available documents.
Blood Viscosity↗
Biomedical subjects
F Nour-Eldin
Publications and source records attributed to F Nour-Eldin.
Falsely prolonged prothrombin time due to an inhibitor to human thromboplastin.
Explore the source record for details and available documents.
Animals↗
Current transfusion problems.
Explore the source record for details and available documents.
Blood Preservation↗
Common problems in blood transfusion.
Prpgress and expansion in transfusion of blood and its products continue. Some common problems are discussed. Certain topical subjects are presented in detail and a new process is outlined for augmenting cryoprecipitate factor VIII activity which could ease the current short supply.
Age Factors↗
Letter: Augmenting cryoprecipitate factor VIII activity.
Explore the source record for details and available documents.
Chemical Precipitation↗
Ultrasonic purification of Bridge anticoagulant neutralizing agent (BANA) and a study on its effect on factor VIII inhibitor.
Ether precipitation of globulins from the supernatant fraction of prothrombin complex concentrate, followed by adsorption on tricalcium phosphate and elution gives a beta2 fraction termed Bridge anticoagulant neutralizing agent (BANA). Although this is completely free of all known blood clotting factors, it improves recalcification time, PTT and thromboplastin generation of hemophilic plasma. It also counteracts the effect of factor VIII inhibitor. Ultrasonic elution produced more activity per mg N than did citrate elution. The possibility is discussed of incorporating BANA preparation in the routine fractionation of plasms without reduction in the yield of factor VIII or prothrombin comples concentrate.
Coagulants↗